Markets:

Overview

News

Currencies

International

Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

3.800 +0.140 (+3.83%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atai Beckley N.V - Common Shares

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

29 30 Next >

Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today ↗

April 22, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87

Via Benzinga

Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29

Via Benzinga

Roth Capital Reveals Top Psychedelic Picks in New Industry Report

April 21, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From April 20, 2022 ↗

April 20, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:

Via Benzinga

Jaden Smith Wants To Be A 'Psychedelics World Leader' After Trying Magic Mushrooms ↗

April 20, 2022

In an interview with Complex to promote his clothing brand MSFTSrep, Jaden Smith talked about his experience with psychedelics and said he is looking to be a “psychedelics world leader.”

Via Benzinga

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

April 19, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33

Via Benzinga

EXCLUSIVE: ATAI Life Sciences Deploys Decentralized Approach To Transform Mental Health Treatments ↗

April 19, 2022

ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments.

Via Benzinga

EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments ↗

April 19, 2022

For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging...

Via Benzinga

EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge ↗

April 19, 2022

The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.

Via Benzinga

Psychedelic Stock Gainers And Losers From April 18, 2022 ↗

April 18, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28

Via Benzinga

Psychedelic Stock Gainers And Losers From April 14, 2022 ↗

April 14, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32

Via Benzinga

Psychedelic Stock Gainers And Losers From April 13, 2022 ↗

April 13, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.41% at $0.24

Via Benzinga

Psychedelic Stock Gainers And Losers From April 11, 2022 ↗

April 11, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17

Via Benzinga

Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗

April 08, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16

Via Benzinga

Christian Angermayer Buys 1 Million Shares Of Atai Life, His Own Company ↗

April 08, 2022

Christian Angermayer, founder and chairman of Atai Life Sciences (Nasdaq: ATAI), told Twitter that he bought 1 million shares of his ...

Via Benzinga

Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 07, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14

Via Benzinga

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 06, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:

Via Benzinga

These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy) ↗

April 06, 2022

What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported...

Via Benzinga

Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More! ↗

April 06, 2022

It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.

Via Benzinga

Psychedelic Stock Gainers And Losers From April 5, 2022 ↗

April 05, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS:

Via Benzinga

Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 04, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18

Via Benzinga

Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity? ↗

April 04, 2022

Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into...

Via Benzinga

Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

April 01, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86

Via Benzinga

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

March 31, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27

Via Benzinga

ATAI Life Sciences's Return On Capital Employed Insights ↗

March 31, 2022

ATAI Life Sciences (NASDAQ:ATAI) brought in sales totaling $230.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 194.78%, resulting in a loss of $93.27...

Via Benzinga

This Biotech Company Is Landing Ketamine-Assisted Therapy In England's Capital ↗

March 31, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. As it pushes ahead with expansion into the United States,...

Via Benzinga

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

March 30, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46

Via Benzinga

atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results ↗

March 30, 2022

atai Life Sciences N.V. (NASDAQ: ATAI) has announced its financial results for the fourth quarter and full year ended December 31, ...

Via Benzinga

Psychedelic Stock Gainers And Losers From March 29, 2022 ↗

March 29, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42

Via Benzinga

Earnings Scheduled For March 30, 2022 ↗

March 30, 2022

Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.

Via Benzinga

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Atai Beckley N.V - Common Shares (NQ:ATAI)

All News about Atai Beckley N.V - Common Shares

Starting at $3.75/week.

Subscribe Today